PHI with Intestinal tuberculosis
How does this condition affect your private health insurance?
Intestinal Tuberculosis (Darm-Tbc) is an extrapulmonary manifestation of Mycobacterium tuberculosis infection, primarily affecting the gastrointestinal tract. It commonly involves the ileocecal region but can occur anywhere from the esophagus to the anus. Symptoms are often non-specific, including abdominal pain, weight loss, fever, night sweats, and changes in bowel habits like diarrhea or constipation. Diagnosis can be challenging, requiring a combination of imaging, endoscopy with biopsy, and microbiological culture. If left untreated, it can lead to severe complications such as intestinal strictures, obstruction, perforation, and malabsorption, significantly impairing quality of life and potentially being fatal.
PKV Risk Assessment
Individual, specialized PHI providers may still insure you, but with a significant surcharge.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Weeks to several months if undiagnosed; treatment typically lasts 6-9 months.
Duration of Illness (Lifetime)
Curable with a full course of antitubercular therapy, usually 6-9 months; chronic or recurrent if treatment is incomplete or ineffective, potentially lifelong.
Cost of Treatment (Initial)
Moderate to high, including diagnostics (endoscopy, biopsy, imaging), potential hospitalization, and a 6-9 month course of antitubercular drugs. Can range from hundreds to thousands of USD.
Cost of Treatment (Lifetime)
Primarily the cost of the initial successful treatment course. If resistant TB or complications arise, costs can be significantly higher due to prolonged hospitalization, surgery, and second-line drugs, potentially tens of thousands of USD.
Mortality Rate
Low with timely and complete treatment (<5%), but significantly higher (20-50%) if untreated, especially in immunocompromised individuals or with complications like perforation.
Risk of Secondary Damages
High if untreated or treatment is delayed, leading to intestinal strictures (up to 50%), obstruction, perforation, fistula formation, malabsorption, and chronic abdominal pain. Surgical intervention may be required.
Probability of Full Recovery
Very high (90-95%) with adherence to a full course of appropriate antitubercular therapy, especially if diagnosed early and without severe complications. Recovery without significant lasting consequences is common.
Underlying Disease Risk
Moderate to high. Increased risk in individuals with immunosuppression (e.g., HIV infection, chronic steroid use, organ transplant recipients), diabetes, chronic kidney disease, malnutrition, and those living in areas with high TB prevalence.